openFDA Drugs@FDA Applications Scraper

Extract official Drugs@FDA application records from openFDA. This actor is useful for pharmaceutical regulatory intelligence, FDA approval research, sponsor tracking, product lifecycle monitoring, and drug application enrichment.

Why this actor

Drugs@FDA application data is useful for pharma analysts, investors, regulatory teams, drug catalog vendors, health-tech products, and competitive-intelligence workflows. It helps connect brand names, generic names, sponsors, application numbers, submissions, approval history, documents, and product NDCs from an official public source.

SEO keywords covered by this Store page include Drugs@FDA scraper, FDA application data API, drug approval database scraper, pharmaceutical sponsor tracking, FDA submission history, ANDA NDA application data, drug product lifecycle monitoring, and pharma regulatory intelligence.

Output

• Application number, sponsor name, brand names, generic names, manufacturer names, and product NDCs
• Products, submission count, latest submission status date, submission type, submission class, and application documents
• Source URL, raw FDA payload, and scrape timestamp

Use cases

• Research FDA application history for branded and generic drugs
• Track sponsor portfolios and submission activity
• Enrich pharma, biotech, investor, and healthcare datasets
• Feed regulatory monitoring systems and AI agents with official FDA application data
• Join application records with openFDA labels, NDC directory, recalls, shortages, and adverse-event datasets

Example input

{
  "brandNames": ["Advil"],
  "sponsorNames": ["Pfizer"],
  "applicationNumbers": ["N020402"],
  "maxResultsPerSearch": 25
}

Agent and automation workflows

Send application rows to Airtable, a warehouse, Make, n8n, or vector search. Agents can summarize sponsor portfolios, group submissions by status date, prepare drug-approval research briefs, or enrich internal product records with official application metadata.

Responsible use

This actor extracts public FDA/openFDA application data for research, enrichment, and monitoring. Do not use the output as medical, legal, or regulatory advice. Verify important decisions against FDA source records and qualified review.

Pricing

Recommended launch pricing: $2-$3 per 1,000 application rows, increasing toward $4-$6 per 1,000 after recurring pharma research usage appears.